ARDANA ANNOUNCES PHASE I RESULTS FOR TESTOSTERONE CREAM

A A

Ardana has reported positive results in a second Phase I study of its testosterone cream, which is being developed as a treatment for testosterone deficiency in male hypogonadism.

Ardana's testosterone cream is expected to have high patient acceptability. The cream is fast drying, has low alcohol content, and only requires application to a small area of the body.

A Phase II dose-finding study in hypogonadal men has also been initiated. Other therapies for male hypogonadism include injectable formulations of testosterone, oral preparations, transdermal patches, topical gels and subcutaneous implants.